The Lp(a)-Lowering Landscape: Navigating Current and Future Therapeutic Options
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- AHA 2025 Clinical Insights: Advancing Cardiology Care
Sotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
Juan Badimon, PhD, FAHA
- AHA 2025 Clinical Insights: Advancing Cardiology Care
Clinical Perspective on New Therapies in Resistant Hypertension
Clyde W. Yancy, MD
- Hypertrophic Cardiomyopathy
Precision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
Ahmad Masri, MD, MS
- Atrial Fibrillation
DARE AF Trial: Dapagliflozin to Reduce AF Burden After Catheter Ablation in Patients Without Diabetes or Heart Failure
Clyde W. Yancy, MD
